Get More Information on Biochips Market- Request Sample Report
The Biochips Market Size was valued at USD 10.09 Billion in 2023, and is expected to reach USD 29.40 Billion by 2032, and grow at a CAGR of 13.29%.
The increased use of biochips in point-of-care diagnosis and molecular diagnostics is expected to drive the demand for these chips, making personalized medicine available. They are specific to normal cells and cancer, associated with the detection of proteins, and allow for speedy analysis of the proteome for protein-based therapeutics. Furthermore, the reliability of these chips to identify diverse biomarkers based on a limited sample and the chip's ability to detect them are also equipped for quick identification and treatment of disease, leading to a substantial need for these chips in personalized drugs.
For a long time, food allergy sufferers, especially those sensitive to pollen, have experienced bouts of fever, hives, or skin reactions arising from memory humoral responses that can lead to vomiting, asthma, and diarrhea. Functioning as a newer avenue, allergy-testing biochips are developing at an escalating rate today. A microarray image of some common allergen components is included in it. This allows for multiple clinical sensitizations to be examined in a single assay. Increasing research for allergy treatments drives demand for biochips. Biochips have high potential to be used in the biosciences sector, as they have been most commonly associated with disease diagnosis and detection, further driving market growth. For example, in April 2021, Toray Industries developed allergy testing biochips that are used to detect multiple allergen-specific immunoglobulin E (IgE) antibodies from trace blood. The growth of this industry is driven by the increased utilization of biochips for allergen detection and testing applications globally.
Key Drivers:
Restraints:
Opportunity:
By Product Type
The DNA chips segment led the market share by product type in 2023, accounting for 38% of the market. DNA chips, also known as DNA microarrays, are capable of performing multiple tests using a single chip. They compete with other molecular methods of high-throughput screening as they enable researchers to analyze thousands to tens of thousands of target DNA sequences in parallel. DNA chips are arrays of specific DNA on a matrix, consisting of small fragments of single-stranded DNA probes that are complementary to the target sequences (DNA or RNA), allowing their complementary sequence to bind to the target. This means they can be used to analyze the expression of genes under certain conditions or to discover genetic mutations in many thousands of samples at one time using modern high-throughput, fluorescent labeling techniques. The proliferation of DNA chips in genomics, genetic screening, and DNA/RNA analysis is driving the growth of the global biochips market.
DNA chips have revolutionized genome-wide association studies and provided genetic underpinnings for numerous conditions. Their ability to comprehensively study hundreds or thousands of genes at one time has significantly fueled genetic research and clinical diagnostics. DNA chips are widely used as a tool for studying cancers by profiling tumors, predicting appropriate therapies, and discovering biomarkers. Due to these characteristics, they are increasingly being used by biopharma companies and research centers. Advances in technology have also led to new uses for DNA chips. Custom DNA microarrays, for instance, allow researchers to prepare chips that are related to their research questions and have higher probe densities, enabling detailed interrogations. Increased clinical needs, including but not limited to non-invasive prenatal testing and pharmacogenomics, are also driving the demand for novel DNA chips.
Need any customization research on Biochips Market - Enquiry Now
By Application
The Biochips Market was dominated by the drug development application segment, which accounted for 41% in 2023. This dominance is supported by the widespread demand for HTS (High Throughput Screening) and personalized medicine. Biochips are used in drug discovery and combinatorial chemistry to rapidly test large numbers of compounds in parallel, leading to accelerated identification of hits, potential leads, or drug candidates. This technique is highly useful for pharmaceutical industries as it reduces the time and overall cost of pharmaceutical R&D.
Additionally, biochips provide an opportunity to study complex biological networks and molecular interactions, which is essential in understanding disease pathways and developing targeted therapy. The growing demand for precision medicine has also triggered the growth of biochips in drug development, especially in oncology, and this is expected to contribute the largest share to the market size by 2023 through increasing deployment, followed by DNA and Protein Microarrays.
In 2023, North America dominated the biochip market, accounting for 49% of the market share. This was due to factors such as the growing elderly population, increased incidence of cardiac diseases, and the presence of well-established healthcare infrastructure, particularly in the U.S. The market growth was also driven by the rising prevalence of chronic diseases like diabetes and the growing demand for both clinical and research diagnostics. Additionally, initiatives promoting precision medicine and increased government investments in cancer genomics, such as the Cancer Moonshot launched in the U.S. in February 2022, further contributed to the region's market share.
The Asia Pacific market is expected to experience rapid growth during the forecast period, attributed to the flourishing pharma and biotech industries in countries like China and India. China's increased investment in scientific research to advance precision medicines has led to improved new drug discoveries. Furthermore, rising investments in genomics, proteomics, and next-generation sequencing research, along with growing patient awareness about advancements in diagnostic technologies, are driving market revenue in the region.
Europe is projected to remain the second-largest market for biochips in 2023, with a healthy revenue CAGR. The region's high utilization of biochips in genomics and proteomics, particularly in the U.K., contributes to this growth. Notably, genomics development projects, such as the 100,000 Genomes Project completed by Genomics England have driven demand in the European market. Sphere Fluidics, a U.K.-based life sciences company, has also developed biochip technology aimed at accelerating single-cell analysis for biopharma and the clinic.
The players operating in the biochips market are the following:
In May 2024, Visionary Holdings Inc., collaborated with Canada's B. Braun Biochip Technology Group to establish Visionary Biotechnology Group Co., Ltd. This collaboration aims to create both financial and social value, contributing positively to Visionary Group's growth in the field of biotechnology at an international level.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 10.09 Billion |
| Market Size by 2032 | US$ 29.40 Billion |
| CAGR | CAGR of 13.29% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Type (DNA Chip, Protein Chip, Lab-on-a-Chip) •By Application (Genomics, Drug Development, Agriculture, Others) •By End-User (Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostics Centers, Academic & Research Institutes, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Agilent Technologies, Inc., PerkinElmer Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Standard BioTools, GE HealthCare, Thermo Fisher Scientific, Inc., LI-COR, Inc., QIAGEN, and Randox Laboratories Ltd. & Other Players |
| Key Drivers | •Rapid Advancements in Nanotechnology Enable the Development of Smaller and More Precise Biochips. •Growing Demand for Personalized Medicine and Point-Of-Care Diagnostics Drives the Need for Rapid and Accurate Biochip-Based Testing. |
| RESTRAINTS | •High Manufacturing Costs Associated with Complex Fabrication Processes Can Limit Market Penetration. •Regulatory Challenges for New Biochip Technologies Can Delay Market Entry. |
Ans: The Biochips Market was valued at USD 10.09 Billion in 2023.
Ans: The expected CAGR of the Global Biochips Market during the forecast period is 13.29%
Ans: DNA chip held the largest share in the Biochips Market in 2023.
Ans: The Biochips Market will be valued at USD 29.40 Billion in 2032.
Ans: The North America led the Biochips Market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume: Device usage volume
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Type launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Biochips Market Segmentation, by Type
7.1 Chapter Overview
7.2 DNA chip
7.2.1 DNA chip Market Trends Analysis (2020-2032)
7.2.2 DNA chip Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Protein chip
7.3.1 Protein Chip Market Trends Analysis (2020-2032)
7.3.2 Protein Chip Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Lab-on-a-chip
7.4.1 Lab-on-a-chip Market Trends Analysis (2020-2032)
7.4.2 Lab-on-a-chip Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Biochips Market Segmentation, by Application
8.1 Chapter Overview
8.2 Genomics
8.2.1 Genomics Market Trends Analysis (2020-2032)
8.2.2 Genomics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Drug Development
8.3.1 Drug Development Market Trends Analysis (2020-2032)
8.3.2 Drug Development Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Agriculture
8.4.1 Agriculture Market Trends Analysis (2020-2032)
8.4.2 Agriculture Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Biochips Market Segmentation, by End-Use
9.1 Chapter Overview
9.2 Biotechnology & Pharmaceutical companies
9.2.1 Biotechnology & Pharmaceutical Companies Market Trends Analysis (2020-2032)
9.2.2 Biotechnology & Pharmaceutical Companies Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Hospitals and Diagnostics Centers
9.3.1 Hospitals and Diagnostics Centers Market Trends Analysis (2020-2032)
9.3.2 Hospitals and Diagnostics Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Academic & Research Institutes
9.4.1 Academic & Research Institutes Market Trends Analysis (2020-2032)
9.4.2 Academic & Research Institutes Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Others
9.5.1 Others Market Trends Analysis (2020-2032)
9.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.4 North America Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.6.2 USA Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.7.2 Canada Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.2.8.2 Mexico Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.6.2 Poland Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.7.2 Romania Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.4 Western Europe Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.6.2 Germany Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.7.2 France Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.8.2 UK Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.9.2 Italy Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.10.2 Spain Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.13.2 Austria Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.4 Asia Pacific Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.6.2 China Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.7.2 India Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.8.2 Japan Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.9.2 South Korea Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.10.2 Vietnam Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.11.2 Singapore Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.12.2 Australia Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.4 Middle East Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.6.2 UAE Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.4 Africa Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Biochips Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.4 Latin America Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.6.2 Brazil Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.7.2 Argentina Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.8.2 Colombia Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Biochips Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Biochips Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Biochips Market Estimates and Forecasts, by End-Use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Type/ Services Offered
11.1.4 SWOT Analysis
11.2 PerkinElmer Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Type/ Services Offered
11.2.4 SWOT Analysis
11.3 Illumina, Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Type/ Services Offered
11.3.4 SWOT Analysis
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Type/ Services Offered
11.4.4 SWOT Analysis
11.5 Standard BioTools
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Type/ Services Offered
11.5.4 SWOT Analysis
11.6 GE HealthCare
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Type/ Services Offered
11.6.4 SWOT Analysis
11.7 Thermo Fisher Scientific, Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Type/ Services Offered
11.7.4 SWOT Analysis
11.8 LI-COR, Inc.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Type/ Services Offered
11.8.4 SWOT Analysis
11.9 QIAGEN
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Type/ Services Offered
11.9.4 SWOT Analysis
11.10 Randox Laboratories Ltd.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Type/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product Type
DNA chip
Protein chip
Lab-on-a-chip
By Application
Genomics
Drug Development
Agriculture
Others
By End User
Biotechnology & Pharmaceutical companies
Hospitals and Diagnostics centres
Academic & Research Institutes
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Medical Gas Analyzers Market Size was valued at USD 300.66 billion in 2023 and is expected to reach USD 417.86 billion by 2031, and grow at a CAGR of 4.2% over the forecast period 2024-2031.
The Single-use Bioprocessing Market size was estimated at USD 27.99 billion in 2023 and is expected to reach USD 108.19 billion by 2032 with a growing CAGR of 16.21% during the forecast period of 2024-2032.
The Epigenetics Market Size was valued at USD 15.2 Billion in 2023 and is expected to reach USD 66 Billion by 2032, growing at a CAGR of 17.7% over the forecast period 2024-2032.
The Lung Cancer Screening Market was valued at USD 3.27 Bn in 2023 and is expected to reach USD 7.22 Bn by 2032 and grow at a CAGR of 9.2% over the forecast period of 2024-2032.
The Dermatology Drugs Market size was USD 41.67 Billion in 2023 and is expected to Reach USD 78.86 Billion by 2031 and grow at a CAGR of 8.3% over the forecast period of 2024-2031.
The Monoclonal Antibody Therapy Market size was valued at USD 87.8 Bn in 2023 and is expected to reach USD 230.38 Bn by 2031 with a growing CAGR of 12.8% Over the Forecast Period of 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
